TELA Bio, Inc., was incorporated in Delaware on April 17, 2012. The company is a commercial stage medical technology company focused on providing innovative soft tissue reconstruction solutions that optimize clinical outcomes by prioritizing preservation and restoration of the patient's own anatomy. The company's growing product portfolio is designed to capitalize on patients' natural healing responses while minimizing long-term exposure to permanent synthetic materials. The company is committed to providing advanced technologies with a strong economic value proposition to assist surgeons and institutions in delivering next-generation soft tissue repair solutions to more patients around the world. Er patient care.